Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001178913-17-001423
Filing Date
2017-05-11
Accepted
2017-05-11 15:59:12
Documents
41
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A zk1719938.htm 10-K/A 304011
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 11694
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 11768
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5610
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5613
12 image00001.jpg GRAPHIC 86678
  Complete submission text file 0001178913-17-001423.txt   1725218

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inks-20161231.xml EX-101.INS 206047
7 XBRL TAXONOMY EXTENSION SCHEMA inks-20161231.xsd EX-101.SCH 23430
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inks-20161231_cal.xml EX-101.CAL 29447
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inks-20161231_def.xml EX-101.DEF 54901
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inks-20161231_lab.xml EX-101.LAB 182207
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inks-20161231_pre.xml EX-101.PRE 126808
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

EIN.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-24431 | Film No.: 17834153
SIC: 2890 Miscellaneous Chemical Products